Sterile Active Pharmaceutical Ingredient Market
Sterile Active Pharmaceutical Ingredients Market Analysis, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredients (HPAPI)) and By Form - Global Market Insights 2022 to 2032
Analysis of Sterile Active Pharmaceutical Ingredient market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sterile Active Pharmaceutical Ingredients Market Outlook (2022-2032)
The global sterile active pharmaceutical ingredients market is valued at US$ 69.7 billion in 2022 and is forecasted to expand at a high CAGR of 6.4% to reach US$ 130.2 billion by 2032.
Increasing applications of monoclonal antibodies will lead them to account for more than 10% share of the global sterile active pharmaceutical ingredients (API) market by 2032.
Report Attributes |
Details |
|---|---|
|
Sterile Active Pharmaceutical Ingredients Market Size (2021A) |
US$ 65.2 Billion |
|
Estimated Market Value (2022E) |
US$ 69.7 Billion |
|
Forecasted Market Value (2032F) |
US$ 130.2 Billion |
|
Global Market Growth Rate (2022-2032) |
6.4% CAGR |
|
North America Market Share (2021) |
~ 26.9% |
|
Europe Market Growth Rate (2022-2032) |
~ 23.7% CAGR |
|
United States Market Growth Rate (2022-2032) |
~5.4% CAGR |
|
Market Share of Top 5 Companies |
~ 14.2% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Historical Sales of Sterile Active Pharmaceutical Ingredients (2017-2021) Vs. Market Forecasts (2022-2032)
Prevalence of chronic diseases related to oncology, cardiology, neurology, etc., has been rising among the population. An effort towards developing drugs that produce the intended effects has positively impacted the sterile active pharmaceutical ingredients market. Strong quality culture and consistent track of regulatory compliance have enabled market players to efficiently manufacture drugs, which has aided the growth of the sterile API market.
The combined use of aqueous and non-aqueous sterile active pharmaceutical ingredients increased by a compound annual growth rate of 6.4% from 2017 to 2021. Stringent regulations by governments on medical product approvals have ensured consumers’ faith in quality, boosting the growth of the pharmaceutical industry.
Growing adoption of technological advancements such as AI by market players to expand their product lines is expected to fuel the sales of sterile APIs. Adoption of targeted therapy drugs by healthcare professionals will uplift the demand for sterile active pharmaceutical ingredients, especially in developed regions.
Fact.MR says that the global sterile active pharmaceutical ingredients market will be valued at US$ 130.2 billion by 2032, expanding at a CAGR of 6.4% over the next ten years.
- Short Term (2022-2025): Rising prevalence of chronic diseases among the geriatric population is expected to mark an increase in the sterile API market during the short term.
- Medium Term (2025-2028): Sterile active pharmaceutical ingredients, being active ingredients in targeted drug therapies, will propel market growth in the mid term.
- Long Term (2028-2032): Investments by market players in R&D to manufacture new drugs will boost pharmaceutical expenditure, thereby dictating the long-term growth of the market.
The global sterile API market exhibited a CAGR of 6.4% between 2017 and 2021, and according to Fact.MR, a market research and competitive intelligence provider, demand is projected to expand at the same 6.4% CAGR between 2022 and 2032.
Why is Demand for Sterile Active Pharmaceutical Ingredients Continuously Rising?
“Sterile API Market Growing in Linearity with Increasing Prevalence of Cardiovascular Diseases”
The use of APIs has expanded to numerous disciplines, including cardiology, nephrology, endocrinology, gastroenterology, ophthalmology, oncology, cardiology, central nervous system (CNS) and neurology, orthopaedics, and pulmonology. Because cardiovascular disorders have become more common than ever, the field of cardiology is projected to become one of the most important sectors for sterile API suppliers.
- The World Health Organization (WHO) estimates that heart attacks and stroke account for around 85% of all fatalities globally.
Increased prevalence of cardiovascular diseases is probably going to spur the expansion of the market for sterile active pharmaceutical ingredients.
“Sterile API Demand Growth Backed by Outsourced Production”
A lot of pharmaceutical businesses are moving away from internal manufacturing and towards outsourcing a variety of manufacturing-related tasks. To control costs, nearly half of the major pharmaceutical companies are outsourcing the production of sterile active pharmaceutical ingredients, which is projected to have an impact on market growth over the study period, which runs from 2022 to 2032.
Nearly 50% of major pharmaceutical corporations worldwide favor manufacturing dosage forms outside their own facilities and producing copyrighted APIs in-house. However, for the production of completed dosage forms, businesses collaborate with several CMOs rather than relying solely on producers. The manufacturing of sterile APIs in North America is balanced between in-house production and outsourcing.
What Factor Do Sterile Active Pharmaceutical Ingredient Manufacturers Need to Keep in Mind?
“Compliance with Changing Regional Regulations - The Key Challenge”
In the United States, 40% of completed drug products and 80% of active pharmaceutical ingredients are imported from outside. The generic medications that are increasingly being prescribed to Americans are primarily made in China and India.
The Food and Drug Administration in the United States is in charge of ensuring that foreign-based manufacturing facilities continue to adhere to Good Manufacturing Practices, a requirement for aseptic pharmaceutical production. But it's not just manufacturing.
Regulatory requirements under the Drug Supply Chain Security Act, which mandates that any corporation intending to sell pharmaceuticals in the U.S. must support product "traceability" by 2023, may soon be placed on shippers and distributors.
Although the law's initial phase of enforcement has been delayed by a year, the supply chain will still need to undergo considerable modifications to fulfil the new standards for traceability and sterilization.
Country-wise Insights
How is Sterile API Production Evolving across the United States?
The United States is a global leader in drug discovery and development owing to high investments in biomedical research. However, it is no longer at the forefront of pharmaceutical production. For a long time, a majority of the medications used by Americans were made within the country. The production of medicines, has, however, steadily shifted outside of the United States in recent years. This is especially true for the production of sterile active pharmaceutical ingredients. Only 28% of API manufacturing units were based in the U.S. as of August 2019.
FDA, however, is optimistic that new manufacturing technology may help American pharmaceutical companies compete more effectively with those in China and other nations, possibly ensuring a steady supply of medicines vital to American patients' health. This is expected to push forward the U.S. sterile API market at a CAGR of 5.4% from 2022 to 2032.
Why is the India Sterile Active Pharmaceutical Ingredients Market Highly Lucrative?
Housing almost 18% of global API manufacturing facilities, India is expected to contribute more than 70% and 10% shares to the South Asia and global sterile API market, respectively.
The Indian pharmaceutical industry has a healthy domestic API market, and many Indian businesses have certain advantages over their Western counterparts. On criteria such as procedural effectiveness and technological prowess, the nation competes on an equal level with Western nations.
The combination of a sophisticated chemical sector, a competent workforce, and strict quality & manufacturing standards is advantageous. Only 2/5 of what it would cost to set up and run a modern company in the West is spent on manufacturing. Additional benefits include low labour expenses and personnel costs.
Because of the high-quality APIs that are produced here, India's API sector has attracted a lot of attention on a global scale. Due to the rising demand for affordable generics and forthcoming developments for the next generation of APIs, the Indian API business has recently experienced phenomenal growth.
The country's API market will undoubtedly grow over the short term thanks to the presence of numerous medium-sized to big API producers and the government's growing focus on the expansion of the pharmaceutical manufacturing industry.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Why are Monoclonal Antibodies Leading the Market?
Increasing applications of monoclonal antibodies are projected to offer an absolute $ opportunity of US$ 28 billion in the sterile API market. Increased demand for biologics is expected to be a major factor propelling the monoclonal antibodies (mAbs) market as a result of the rising prevalence of chronic diseases, including cancer, cardiovascular disorders, and others.
Similar to this, growing mAb therapy applications for targeted therapies and increased patient and physician knowledge of such therapies are anticipated to have a substantial impact on market growth.
Furthermore, the COVID-19 pandemic boosted the chances of market expansion by encouraging the creation of several mAbs that target the SARS-CoV-2 virus. Several of these antibodies have received emergency use authorizations (EUA) from the U.S. FDA because mAbs constitute a promising alternative for mitigating COVID-19 because of their safety and effectiveness.
Additionally, the U.S. Department of Health and Human Services announced the distribution of at least 600,000 free bebtelovimab courses and optional future purchase of 500,000 additional doses, resulting in fresh prospects for mAb growth.
There have been several new product launches and approvals in this field as a result of the key benefits that mAb treatments have over earlier therapies in terms of specificity, efficacy, and ease of delivery. The U.S. FDA has approved more than 100 mAb products, and the range of therapeutic mAb uses is anticipated to expand further thanks to the creation of sophisticated therapeutic options like antibody fragments, derivatives, and bispecific antibodies.
Competitive Landscape
Prominent sterile active pharmaceutical ingredient manufacturers are Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Corden Pharma GmbH, Dalton Pharma Services, Pfizer Inc, Sun Pharmaceutical Industries Ltd., Lonza Group, Albany Molecular Research Inc., Sanofi S.A., and Dr. Reddy’s Laboratories Ltd.
A growing need for parenteral medications, biologics, and ophthalmic solutions has manufacturers concentrating on growing their product lines related to sterile active pharmaceutical ingredients. Increasing production capacities is being accomplished by key industry participants using acquisition and merger tactics.
- In September 2019, ten23 health, a global contract development and manufacturing organization (CDMO), announced the completion of a new sterile manufacturing facility in Visp, Switzerland.
Fact.MR has provided detailed information about the price points of key manufacturers of sterile active pharmaceutical ingredients positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Sterile Active Pharmaceutical Ingredients Industry Research
-
By Product Type :
- Monoclonal Antibodies
- Immunoglobulin
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Peptide Antibiotics
- Vaccines
- Small Molecule Antibiotics
- Highly Potent Active Pharmaceutical Ingredients (HPAPI)
- Others
-
By Form :
- Aqueous
- Non-aqueous Liquid
- Dry Powder
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Sterile Active Pharmaceutical Ingredients Market - Executive Summary 2. Market Overview 2.1. Market Definition and Introduction 2.2. Market Taxonomy/ Research Scope 3. Market Background and Foundation Data 3.1. Global Pharmaceutical Ingredients Market Outlook 3.2. Active Pharmaceuticals Industry Outlook 3.3. API Manufacturing Facility Distribution, By Country 3.4. Number of Hospitals & Pulmonary Clinics Per 1000 Population 3.5. Sterile Active Pharmaceuticals Product Type Analysis 3.5.1. By Region 3.5.2. By Key companies 3.6. Growth & Development Pattern in Sterile Active Pharmaceutical Ingredients Market 3.7. Sterile Active Pharmaceuticals Opportunity Assessment 3.7.1. Total Available Market (US$ Billion) 3.7.2. Serviceable Addressable Market (US$ Billion) 3.7.3. Serviceable Obtainable Market (US$ Billion) 3.8. Market White Space Assessment 3.9. Market Dynamics 3.9.1. Market Growth Drivers 3.9.2. Market Restraints 3.9.3. Market Opportunity 3.9.4. Market Trends 3.10. Forecast and Macro-Economic Factors – Relevance and Impact 3.11. PESTLE Analysis 3.12. Porter’s Five Force Analysis 3.13. Investment Feasibility Analysis 3.14. Key Success Factors 4. Global Sterile Active Pharmaceutical Ingredients Market - Pricing Analysis 4.1. Product Type and Country-Level Pricing Analysis 4.2. Global Average Pricing Analysis Benchmark 4.3. Factors Influencing Pricing 5. Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Billion) Analysis and Forecast 5.1. Historical Market Value (US$ Billion) Analysis, 2017-2021 5.2. Current and Future Market Value (US$ Billion) Projections, 2022-2032 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size (US$ Billion) Analysis By Product Type, 2017-2021 6.3. Current and Future Market Size (US$ Billion) Analysis, Forecast By Product Type, 2022-2032 6.3.1. Monoclonal Antibodies 6.3.2. Immunoglobulin 6.3.3. Cytokines 6.3.4. Insulin 6.3.5. Peptide Hormones 6.3.6. Blood Factors 6.3.7. Peptide Antibiotics 6.3.8. Vaccines 6.3.9. Small Molecule Antibiotics 6.3.10. Highly Potent Active Pharmaceutical Ingredients (HPAPI) 6.3.11. Others 6.4. Market Attractiveness Analysis By Product Type 7. Global Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast, By Form 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Billion), Analysis By Form, 2017-2021 7.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Form, 2022-2032 7.3.1. Aqueous 7.3.2. Non-Aqueous Liquid 7.3.3. Dry Powder 7.4. Market Attractiveness Analysis By Form 8. Global Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast, By Region 8.1. Introduction 8.2. Historical Market Size (US$ Billion) Analysis By Region, 2017-2021 8.3. Current Market Size (US$ Billion) Analysis Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & ASEAN 8.3.6. Oceania 8.3.7. Middle East & Africa 8.4. Market Attractiveness Analysis By Region 9. North America Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 9.1. Introduction / Key Findings 9.2. Pricing Analysis 9.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 9.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 9.4.1. By Country 9.4.1.1. U.S. 9.4.1.2. Canada 9.4.2. By Product Type 9.4.3. By Form 9.5. Market Attractiveness Analysis 9.5.1. By Country 9.5.2. By Product Type 9.5.3. By Form 10. Latin America Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 10.1. Introduction / Key Findings 10.2. Pricing Analysis 10.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 10.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 10.4.1. By Country 10.4.1.1. Brazil 10.4.1.2. Mexico 10.4.1.3. Argentina 10.4.1.4. Rest of Latin America 10.4.2. By Product Type 10.4.3. By Form 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Product Type 10.5.3. By Form 11. Europe Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 11.1. Introduction / Key Findings 11.2. Pricing Analysis 11.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 11.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 11.4.1. By Country 11.4.1.1. Germany 11.4.1.2. France 11.4.1.3. Italy 11.4.1.4. Spain 11.4.1.5. U.K. 11.4.1.6. BENELUX 11.4.1.7. Russia 11.4.1.8. Rest of Europe 11.4.2. By Product Type 11.4.3. By Form 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Product Type 11.5.3. By Form 12. East Asia Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 12.1. Introduction / Key Findings 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 12.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 12.4.1. By Country 12.4.1.1. China 12.4.1.2. Japan 12.4.1.3. South Korea 12.4.2. By Product Type 12.4.3. By Form 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By Form 13. South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 13.1. Introduction / Key Findings 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 13.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 13.4.1. By Country 13.4.1.1. India 13.4.1.2. Thailand 13.4.1.3. Indonesia 13.4.1.4. Malaysia 13.4.1.5. Rest of South Asia & ASEAN 13.4.2. By Product Type 13.4.3. By Form 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Form 14. Oceania Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 14.1. Introduction / Key Findings 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 14.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 14.4.1. By Country 14.4.1.1. Australia 14.4.1.2. New Zealand 14.4.2. By Product Type 14.4.3. By Form 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Form 15. Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 15.1. Introduction / Key Findings 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 15.4. Market Size (US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Northern Africa 15.4.1.4. Turkey 15.4.1.5. Rest of Middle East & Africa 15.4.2. By Product Type 15.4.3. By Form 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Form 16. Country-level Sterile Active Pharmaceutical Ingredients Market Analysis and Forecast 16.1. Introduction / Key Findings 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Sterile Active Pharmaceutical Ingredients Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.2.2.1. By Product Type 16.2.2.2. By Form 16.3. Canada Sterile Active Pharmaceutical Ingredients Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.3.2.1. By Product Type 16.3.2.2. By Form 16.4. Brazil Sterile Active Pharmaceutical Ingredients Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.4.2.1. By Product Type 16.4.2.2. By Form 16.5. Mexico Sterile Active Pharmaceutical Ingredients Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.5.2.1. By Product Type 16.5.2.2. By Form 16.6. Argentina Sterile Active Pharmaceutical Ingredients Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.6.2.1. By Product Type 16.6.2.2. By Form 16.7. Germany Sterile Active Pharmaceutical Ingredients Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.7.2.1. By Product Type 16.7.2.2. By Form 16.8. France Sterile Active Pharmaceutical Ingredients Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.8.2.1. By Product Type 16.8.2.2. Form 16.9. Italy Sterile Active Pharmaceutical Ingredients Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.9.2.1. By Product Type 16.9.2.2. By Form 16.10. Spain Sterile Active Pharmaceutical Ingredients Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.10.2.1. By Product Type 16.10.2.2. By Form 16.11. BENELUX Sterile Active Pharmaceutical Ingredients Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.11.2.1. By Product Type 16.11.2.2. By Form 16.12. Russia Sterile Active Pharmaceutical Ingredients Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.12.2.1. By Product Type 16.12.2.2. By Form 16.13. U.K. Sterile Active Pharmaceutical Ingredients Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.13.2.1. By Product Type 16.13.2.2. By Form 16.14. China Sterile Active Pharmaceutical Ingredients Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.14.2.1. By Product Type 16.14.2.2. By Form 16.15. Japan Sterile Active Pharmaceutical Ingredients Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.15.2.1. By Product Type 16.15.2.2. By Form 16.16. South Korea Sterile Active Pharmaceutical Ingredients Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.16.2.1. By Product Type 16.16.2.2. By Form 16.17. India Sterile Active Pharmaceutical Ingredients Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.17.2.1. By Product Type 16.17.2.2. By Form 16.18. ASEAN Countries Sterile Active Pharmaceutical Ingredients Market Analysis 16.18.1. Value Proportion Analysis by Market Taxonomy 16.18.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.18.2.1. By Product Type 16.18.2.2. By Form 16.19. Australia Sterile Active Pharmaceutical Ingredients Market Analysis 16.19.1. Value Proportion Analysis by Market Taxonomy 16.19.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.19.2.1. By Product Type 16.19.2.2. By Form 16.20. New Zealand Sterile Active Pharmaceutical Ingredients Market Analysis 16.20.1. Value Proportion Analysis by Market Taxonomy 16.20.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.20.2.1. By Product Type 16.20.2.2. By Form 16.21. GCC Countries Sterile Active Pharmaceutical Ingredients Market Analysis 16.21.1. Value Proportion Analysis by Market Taxonomy 16.21.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.21.2.1. By Product Type 16.21.2.2. By Form 16.22. Turkey Sterile Active Pharmaceutical Ingredients Market Analysis 16.22.1. Value Proportion Analysis by Market Taxonomy 16.22.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.22.2.1. By Product Type 16.22.2.2. By Form 16.23. Northern Africa Sterile Active Pharmaceutical Ingredients Market Analysis 16.23.1. Value Proportion Analysis by Market Taxonomy 16.23.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.23.2.1. By Product Type 16.23.2.2. By Form 16.24. South Africa Sterile Active Pharmaceutical Ingredients Market Analysis 16.24.1. Value Proportion Analysis by Market Taxonomy 16.24.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.24.2.1. By Product Type 16.24.2.2. By Form 16.25. Rest of Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Analysis 16.25.1. Value Proportion Analysis by Market Taxonomy 16.25.2. Value (US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 16.25.2.1. By Product Type 16.25.2.2. By Form 17. Sterile Active Pharmaceutical Ingredients Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration of Players 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 18. Sterile Active Pharmaceutical Ingredients Market Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking of Product Types 18.3. Competition Deep Dive 18.3.1. Aurobindo Pharma Limited 18.3.1.1. Overview 18.3.1.2. Product Type Portfolio 18.3.1.3. Key Financials 18.3.1.4. Sales Footprint 18.3.1.5. SWOT Analysis 18.3.1.6. Key Developments 18.3.1.7. Strategy Overview 18.3.2. Corden Pharma GmbH 18.3.2.1. Overview 18.3.2.2. Product Type Portfolio 18.3.2.3. Key Financials 18.3.2.4. Sales Footprint 18.3.2.5. SWOT Analysis 18.3.2.6. Key Developments 18.3.2.7. Strategy Overview 18.3.3. Pfizer Inc. 18.3.3.1. Overview 18.3.3.2. Product Type Portfolio 18.3.3.3. Key Financials 18.3.3.4. Sales Footprint 18.3.3.5. SWOT Analysis 18.3.3.6. Key Developments 18.3.3.7. Strategy Overview 18.3.4. Sun Pharmaceutical Industries Ltd. 18.3.4.1. Overview 18.3.4.2. Product Type Portfolio 18.3.4.3. Key Financials 18.3.4.4. Sales Footprint 18.3.4.5. SWOT Analysis 18.3.4.6. Key Developments 18.3.4.7. Strategy Overview 18.3.5. Lonza Group 18.3.5.1. Overview 18.3.5.2. Product Type Portfolio 18.3.5.3. Key Financials 18.3.5.4. Sales Footprint 18.3.5.5. SWOT Analysis 18.3.5.6. Key Developments 18.3.5.7. Strategy Overview 18.3.6. Curia 18.3.6.1. Overview 18.3.6.2. Product Type Portfolio 18.3.6.3. Key Financials 18.3.6.4. Sales Footprint 18.3.6.5. SWOT Analysis 18.3.6.6. Key Developments 18.3.6.7. Strategy Overview 18.3.7. Sanofi S.A 18.3.7.1. Overview 18.3.7.2. Product Type Portfolio 18.3.7.3. Key Financials 18.3.7.4. Sales Footprint 18.3.7.5. SWOT Analysis 18.3.7.6. Key Developments 18.3.7.7. Strategy Overview 18.3.8. Dr. Reddy’s Laboratories Ltd 18.3.8.1. Overview 18.3.8.2. Product Type Portfolio 18.3.8.3. Key Financials 18.3.8.4. Sales Footprint 18.3.8.5. SWOT Analysis 18.3.8.6. Key Developments 18.3.8.7. Strategy Overview 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Region, 2017-2021
Table 02: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Region, 2022-2032
Table 03: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 04: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 05: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 06: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 07: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 08: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 09: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 10: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 11: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 12: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 13: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 14: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 15: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 16: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 17: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 18: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 19: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 20: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 21: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 22: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 23: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 24: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 25: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 26: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 27: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 28: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 29: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 30: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 31: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 32: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 33: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 34: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 35: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 36: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
Table 37: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2017-2021
Table 38: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Country, 2022-2032
Table 39: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2017-2021
Table 40: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Product Type, 2022-2032
Table 41: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2017-2021
Table 42: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) and Forecast by Form, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 02: Global Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 03: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Region, 2022 & 2032
Figure 04: Global Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Region, 2022-2032
Figure 05: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 06: Global Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 07: Global Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 08: Global Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 09: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 10: North America Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 11: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 12: North America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 13: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 14: North America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 15: North America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 16: North America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 17: North America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 18: North America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 19: North America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 20: Latin America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 21: Latin America Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 22: Latin America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 23: Latin America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 24: Latin America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 25: Latin America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 26: Latin America Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 27: Latin America Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 28: Latin America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 29: Latin America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 30: Latin America Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 31: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 32: Europe Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 33: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 34: Europe Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 35: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 36: Europe Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 37: Europe Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 38: Europe Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 39: Europe Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 40: Europe Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 41: Europe Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 42: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 43: East Asia Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 44: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 45: East Asia Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 46: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 47: East Asia Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 48: East Asia Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 49: East Asia Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 50: East Asia Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 51: East Asia Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 52: East Asia Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 53: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 54: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 55: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 56: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 57: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 58: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 59: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 60: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 61: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 62: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 63: South Asia & ASEAN Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 64: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 65: Oceania Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 66: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 67: Oceania Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 68: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 69: Oceania Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 70: Oceania Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 71: Oceania Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 72: Oceania Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 73: Oceania Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 74: Oceania Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Figure 75: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) Forecast, 2022-2032
Figure 76: MEA Sterile Active Pharmaceutical Ingredients Market Absolute $ Opportunity (USD Billion), 2022-2032
Figure 77: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Country, 2022 & 2032
Figure 78: MEA Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 79: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Product Type, 2022 & 2032
Figure 80: MEA Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 81: MEA Sterile Active Pharmaceutical Ingredients Market Value (USD Billion) by Form, 2022 & 2032
Figure 82: MEA Sterile Active Pharmaceutical Ingredients Market Y-o-Y Growth Rate by Form, 2022-2032
Figure 83: MEA Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Country, 2022-2032
Figure 84: MEA Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Product Type, 2022-2032
Figure 85: MEA Sterile Active Pharmaceutical Ingredients Market Attractiveness Analysis by Form, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what CAGR did the sterile active pharmaceutical ingredients expand historically?
From 2017 to 2021, sales of sterile active pharmaceutical ingredients increased at 6.4% CAGR.
What is the size of the global sterile API market?
The global sterile active pharmaceutical ingredients market is valued at US$ 69.7 billion in 2022.
How is the market expected to fare going forward?
Global demand for sterile APIs is anticipated to reach US$ 130.2 billion by 2032-end.
Which regional market enjoys a leading position?
North America leads the global sterile active pharmaceutical ingredients market accounting for 26.9% market share in 2021.
Which drug class holds the highest market share?
Monoclonal antibodies account for 26.6% share of the global market.
Sterile Active Pharmaceutical Ingredient Market